Adel Naimi
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Cell death mechanisms and regulation 5
- RNA Interference and Gene Delivery 3
- Retinoids in leukemia and cellular processes 2
- Genetics 4
- Mesenchymal stem cell research 4
- Co-authors
- Ali Hassanzadeh (11 shared papers)Wanich Suksatan (2 shared papers)Alexei Valerievich Yumashev (2 shared papers)Lakshmi Thangavelu (2 shared papers)Ehsan Razeghian (1 shared paper)Ahmed Raji (1 shared paper)Ali Noroozi‐Aghideh (2 shared papers)Supat Chupradit (1 shared paper)
In The Last Decade
Adel Naimi
15 papers receiving 638 citations
Adel Naimi's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 291
- Immunology 199
- Genetics 73
- Cancer Research 66
- Molecular Biology 226
Countries citing papers authored by Adel Naimi
This map shows the geographic impact of Adel Naimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Naimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Naimi more than expected).
Fields of papers citing papers by Adel Naimi
This network shows the impact of papers produced by Adel Naimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Naimi. The network helps show where Adel Naimi may publish in the future.
Co-authors
The 25 scholars most cited alongside Adel Naimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons Hit paper breakdown → | 2022 | 306 |
| 2 | 2020 | 65 | |
| 3 | 2021 | 56 | |
| 4 | 2018 | 37 | |
| 5 | 2017 | 36 | |
| 6 | 2018 | 36 | |
| 7 | 2021 | 32 | |
| 8 | 2019 | 19 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 3 | |
| 15 | 2021 | 2 |
About Adel Naimi
Adel Naimi is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Hematology, having authored 15 papers that have together received 643 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Mesenchymal stem cell research (4 papers), RNA Interference and Gene Delivery (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Phagocytosis and Immune Regulation (2 papers), CAR-T cell therapy research (2 papers), NF-κB Signaling Pathways (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Oncology (291 citations), Immunology (199 citations), Genetics (73 citations), Cancer Research (66 citations) and Molecular Biology (226 citations). Adel Naimi has collaborated with scholars based in Iran, Iraq and Thailand. Frequent co-authors include Ali Hassanzadeh, Wanich Suksatan, Alexei Valerievich Yumashev, Lakshmi Thangavelu, Ehsan Razeghian, Ahmed Raji, Ali Noroozi‐Aghideh, Supat Chupradit, Navid Shomali and Ali Adili. Their work appears in journals such as Journal of Cellular Physiology, Anti-Cancer Agents in Medicinal Chemistry, Journal of Clinical Laboratory Analysis, Biomedicine & Pharmacotherapy and Advanced Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.